Overview
Retatrutide is a novel peptide studied as a triple hormone receptor agonist, interacting with GLP-1, GIP, and glucagon receptors. This Cambridge Research formulation provides 8 mg per vial, designed for advanced metabolic and weight-regulation research.
Key Features
-
Triple-Receptor Agonist: GLP-1, GIP, and glucagon activity
-
Accurate Dosage: 8 mg per vial
-
Convenient Packaging: Supplied in 3 vials with bacteriostatic water
-
Premium Manufacturing Standards: Ensures stability and reliability
Benefits
-
Commonly researched for metabolic regulation and energy balance
-
Frequently associated with weight-management and fat-metabolism studies
-
Studied for its role in glucose control and appetite signaling
-
Suitable for advanced endocrine research environments
Usage & Handling
For research use only. Follow proper preparation, storage, and handling procedures to maintain compound integrity.
Why Choose Retatrutide 8 mg?
Retatrutide 8 mg from Cambridge Research offers consistent quality, precise dosing, and advanced formulation, making it a dependable option for cutting-edge metabolic research.
No reviews found!
No comments found for this product. Be the first to comment!